U.S., Jan. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07342075) titled 'Registry Study of Cerebral Small Vessel Disease' on Jan. 06.
Brief Summary: The incidence of cerebral small vessel disease (CSVD) increases with age, affecting approximately 5% of individuals over 50 years old and nearly all individuals over 90 years old. CSVD is also the most important vascular factor contributing to cognitive decline, with 45% of dementia patients attributed to CSVD. Existing interventions are similar to secondary prevention strategies for cardiovascular and cerebrovascular diseases, and no specific therapies are currently available.
CSVD-related cognitive impairment (CSVDCI) predominantly involves attention, pro...